Kunshan RiboQuark Pharmaceutical Technology
About:
Kunshan RiboQuark Pharmaceutical Technology develops siRNA-based preclinical drug candidates and products for the prevention of hair loss.
Top Investors: BVCF
Description:
Kunshan RiboQuark Pharmaceutical Technology Co., Ltd. develops siRNA based preclinical drug candidates. Its products include QPI-1007, an ocular neuroprotectant. The company also develops siRNA-based cosmetic product for the prevention of hair loss. The company was founded in 2012 and is based in Kunshan, China.
Total Funding Amount:
$7.45M
Headquarters Location:
Kunshan, Anhui, China
Founded Date:
2012-01-01
Founders:
Daniel Zurr
Number of Employees:
1-10
Last Funding Date:
2014-01-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai